November 2026
|
16
NMIBC Guideline Update for APPs: What's Changed and Why it MattersThis interactive, 90-minute case based discussion is designed specifically for APPs. This course will address key educational gaps and barriers in the latest advancements in non-muscle invasive bladder cancer care as documented in the AUA’s Bladder Cancer Global Needs Assessment and is coupled with the latest updates from the newly released Diagnoses and Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC): AUA/Society for Urologic Oncology (SUO) Guidelines Amendment (2026).Join us to discuss the impacts of the recent AUA/ SUO NMIBC Guideline updates and how risk stratification frameworks apply for optimal patient selection and treatment coordination. The panel will dive into practical ways to integrate novel therapies into NMIBC care management, monitoring adverse effects and applying shared decision making and patient centered approaches for improved outcomes. Virtual View Course |